Drug
Cdx 011
Cdx 011: highest development phase Phase 2, developed by Celldex Therapeutics. 2 trial records tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Celldex Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| CDX-011 NCT01156753 | Phase 2 | Breast Cancer |
| CDX-011 NCT01997333 | Phase 2 | Metastatic gpNMB Over-expressing Triple Negative Breast Cancer |
Latest
No recent events.
Follow Cdx 011 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.